Litigation

Federal Judge Halts National Elmiron Class Action; Multidistrict Litigation to Continue

by

A federal judge has recently decided against allowing a national class action lawsuit for individuals claiming harm from the drug Elmiron, though the legal challenges will continue under multidistrict litigation (MDL). This decision reflects the complex landscape of mass litigation cases where thousands seek justice for alleged wrongs committed by corporations or manufacturers. Elmiron, a prescription drug used for treating bladder pain, has been at the center of legal scrutiny after patients reported experiencing vision problems allegedly linked to the medication. The lawsuits demand accountability from the manufacturers, claiming that the risks were not properly … Read more

Hidden Finances: Exploring the Effects of Secret Litigation Funding in the MedTech Sector

by

Washington, D.C. – In the complex realm of medical technology, a stealthy financial player is emerging: undisclosed third-party litigation funding (TPLF). This behind-the-scenes funding influences legal actions involving medical technologies and devices, yet operates with a degree of opacity that raises concerns about the integrity of litigations and the healthcare sector overall. Third-party litigation funding is not a new concept, but its encroachment into the medtech industry marks a significant evolution. Traditionally employed in other legal areas, TPLF involves third parties—often hedge funds or investment companies—that finance lawsuits in exchange for a portion of the … Read more

Class Action Attorneys Contest New Draft Rule Said to Conflate Key Legal Practices in Multidistrict Litigation

by

WASHINGTON, D.C. — Legal professionals specializing in class action lawsuits are rallying for significant amendments to a proposed regulation concerning multidistrict litigation (MDL). They argue that the draft rule, designed to streamline early-stage litigation for cases consolidated from different jurisdictions, does not adequately distinguish between mass torts and class actions. These litigators claim the rule could disrupt long-established best practices for managing class-related MDLs. The proposed changes, which underwent scrutiny by the judiciary’s Advisory Committee on Civil Rules earlier this year, aim primarily to aid judges new to MDL responsibilities. By pushing lawyers to agree … Read more

Exploring Potential Mass Tort Litigation: Depo-Provera Cases and Rulemaking Committee’s Role in Legal Funding Decisions

by

Depo-Provera, a long-used injectable contraceptive, is stepping into the legal spotlight as concerns about its potential health risks might bring a wave of litigation, identifying it as a possible new mass tort scenario. Legal experts are debating the implications, considering previous lawsuits that claimed insufficient warning about bone density loss associated with the drug’s prolonged use. With these discussions underway, a committee on judicial proceedings may soon evaluate how litigation funding can influence such lawsuits. The issue of third-party financing in the legal system is contentious, raising questions about the impact on case outcomes and … Read more